openPR Logo
Press release

Cox-2 Inhibitors Market Size, Share, Development by 2024

04-03-2019 04:41 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global Info Research

Cox-2 Inhibitors Market Size, Share, Development by 2024

Global Info Research offers a latest published report on Cox-2 Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-cox-2-inhibitors-market_p108144.html
 
Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.

Scope of the Report:
The global Cox-2 Inhibitors market is valued at x million USD in 2018 and is expected to reach x million USD by the end of 2024, growing at a CAGR of x% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cox-2 Inhibitors.
Europe also play important roles in global market, with market size of x million USD in 2019 and will be x million USD in 2024, with a CAGR of x%.
This report studies the Cox-2 Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cox-2 Inhibitors market by product type and applications/end industries.

Market Segment by Companies, this report covers
    Bayer
    Novartis
    Pfizer
    Merck
    Cadila Pharmaceuticals
    Sabinsa Corporation

Market Segment by Regions, regional analysis covers 
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Selective Cox-2 Inhibitors
    Non Selective Cox-2 Inhibitors

Market Segment by Applications, can be divided into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

For More Information On This Report, Please Visit @
 https://www.globalinforesearch.com/global-cox-2-inhibitors-market_p108144.html

Related Information:
North America Cox-2 Inhibitors Market Growth 2019-2024
United States Cox-2 Inhibitors Market Growth 2019-2024
Asia-Pacific Cox-2 Inhibitors Market Growth 2019-2024
Europe Cox-2 Inhibitors Market Growth 2019-2024
EMEA Cox-2 Inhibitors Market Growth 2019-2024
Global Cox-2 Inhibitors Market Growth 2019-2024
China Cox-2 Inhibitors Market Growth 2019-2024

Customization Service of the Report :
Market Research Report Store provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:
Market Research Report Store (MRRS) is a professional organization related to market research reports in all directions .To provide customers with a variety of market research reports, MRRS cooperates with a large of famous market report publishers all over the world. Owing to our good service and the professional market reports in the wide range, MRRS enjoys a good reputation in the market. In pace with the development of MRRS, more and more customers and market report publishers choose to cooperate with us. As a specialized platform, MRRS upholds the supremacy of customers and aims to provide customers with better service and richer select.

Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
Website: http://www.globalinforesearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cox-2 Inhibitors Market Size, Share, Development by 2024 here

News-ID: 1684564 • Views: 202

More Releases from Global Info Research

Global Industrial Plasma Cutters Market: Size,Share,Analysis,Regional Outlook an …
Global Info Research offers a latest published report on Industrial Plasma Cutters Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Industrial Plasma Cutters players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Smart Valve Positioners Market: Size,Share,Analysis,Regional Outlook and …
Global Info Research offers a latest published report on Smart Valve Positioners Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Smart Valve Positioners players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Food Tray Sealing Machines Market: Size,Share,Analysis,Regional Outlook a …
Global Info Research offers a latest published report on Food Tray Sealing Machines Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Food Tray Sealing Machines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report
Global Floor Scrubbing Machines Market: Size,Share,Analysis,Regional Outlook and …
Global Info Research offers a latest published report on Floor Scrubbing Machines Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Floor Scrubbing Machines players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure

All 5 Releases


More Releases for Inhibitors

Global Protein Kinase Inhibitors Market Research Report
This report studies the global Protein Kinase Inhibitors market status and forecast, categorizes the global Protein Kinase Inhibitors market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bayer Astra Zeneca Roche Teva Apotex Novartis Glaxosmithkline Pfizer Geographically, this report studies the top
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These
Tyrosine Kinase Inhibitors - Pipeline Insights 2017
The “Tyrosine kinase Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of tyrosine kinase inhibitor drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential Akt inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,
AKT Inhibitors - Pipeline Insights 2017
The “AKT Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of AKT drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential AKT inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent, and USFDA and
AKT Inhibitors - Pipeline Insights 2017
The “AKT Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of AKT drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential AKT inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent, and USFDA and
CDK Inhibitors Therapeutics Pipeline Analysis 2017
The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation. Explore Report at: www.psmarketresearch.com/market-analysis/cdk-inhibitors-therapeutics-pipeline-analysis USFDA granted Breakthrough Therapy Designation to a drug